-
Scott Kopetz, who specializes in gastrointestinal cancer at M.
WSJ: 'Personalized Medicine' Hits a Bump
-
" Says Robert Mayer , director of the center for gastrointestinal oncology at the Dana-Farber Cancer Institute: "I think it's hard to be anything but enthusiastic about the results.
FORBES: Magazine Article
-
In fact, says Robert Mayer Robert Mayer , director for the center of gastrointestinal oncology at the Dana-Farber Cancer Center, the statins are enticing but less promising than other drugs developed more specifically for cancer.
FORBES: Can Cholesterol Drugs Prevent Cancer?
-
In fact, says Robert Mayer , director for the center of gastrointestinal oncology at the Dana-Farber Cancer Center, the statins are enticing but less promising than other drugs developed more specifically for cancer.
FORBES: Can Cholesterol Drugs Prevent Cancer?
-
Night shift workers are far more prone to having sleep disorders, gastrointestinal disorders, metabolic problems, cancer, diabetes, depression and a number of other health problems.
BBC: The cities that never sleep
-
Abraxane, a cancer chemotherapy made by Celgene, slowed tumor growth and cut the risk of death in patients with advanced pancreatic cancer, according to results that will be presented at a conference on gastrointestinal tumors being held by the American Society of Clinical Oncology.
FORBES: Celgene's Abraxane Extends Life By 1.8 Months In Advanced Pancreatic Cancer
-
Sutent is being submitted for both gastrointestinal stromal tumors that have failed to respond to Gleevec, a drug from Novartis and for kidney cancer that has not responded to other treatments.
FORBES: Magazine Article